Targeting Lyn regulates Snail family shuttling and inhibits metastasis
D Thaper1,2, S Vahid1,2, K M Nip1,2
1Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Abstract:
The acquisition of an invasive phenotype by epithelial cells occurs through a loss of cellular adhesion and polarity, heralding a multistep process that leads to metastatic dissemination. Since its characterization in 1995, epithelial-mesenchymal transition (EMT) has been closely linked to the metastatic process. As a defining aspect of EMT, loss of cell adhesion through downregulation of E-cadherin is carried out by several transcriptional repressors; key among them the SNAI family of transcription factors. Here we identify for the first time that Lyn kinase functions as a key modulator of SNAI family protein localization and stability through control of the Vav-Rac1-PAK1 (Vav-Rac1-p21-activated kinase) pathway. Accordingly, targeting Lyn in vitro reduces EMT and in vivo reduces metastasis of primary tumors. We also demonstrate the clinical relevance of targeting Lyn as a key player controlling EMT; patient samples across many cancers revealed a strong negative correlation between Lyn and E-cadherin, and high Lyn expression in metastatic tumors as well as metastasis-prone primary tumors. This work reveals a novel pancancer mechanism of Lyn-dependent control of EMT and further underscores the role of this kinase in tumor progression.
Insights
This study reveals Lyn kinase controls epithelial-mesenchymal transition (EMT) by regulating SNAI proteins. Targeting Lyn kinase reduces cancer metastasis and E-cadherin loss, offering a new therapeutic strategy for various cancers.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for cancer metastasis.
- EMT involves loss of cell adhesion and polarity, often mediated by SNAI transcription factors.
- Understanding regulators of SNAI proteins is key to inhibiting metastasis.
Purpose of the Study:
- To identify novel regulators of SNAI protein function in EMT.
- To investigate the role of Lyn kinase in controlling SNAI protein localization and stability.
- To evaluate Lyn kinase as a potential therapeutic target for reducing cancer metastasis.
Main Methods:
- Investigated Lyn kinase's role in modulating SNAI protein localization and stability.
- Utilized the Vav-Rac1-PAK1 pathway as a mechanistic link.
- Assessed the effect of targeting Lyn kinase on EMT in vitro and metastasis in vivo.
- Analyzed patient cancer samples to correlate Lyn expression with E-cadherin and metastatic status.
Main Results:
- Lyn kinase was identified as a key modulator of SNAI family protein localization and stability.
- Targeting Lyn kinase reduced EMT in vitro and primary tumor metastasis in vivo.
- A negative correlation between Lyn and E-cadherin was observed across multiple cancer types.
- High Lyn expression correlated with metastatic and metastasis-prone tumors.
Conclusions:
- Lyn kinase plays a critical role in a novel, pancancer mechanism controlling EMT.
- Lyn kinase regulates EMT via the Vav-Rac1-PAK1 pathway, impacting SNAI protein function.
- Targeting Lyn kinase represents a promising strategy to inhibit cancer progression and metastasis.
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
lncRNA - Long Non-coding RNAs
Non-Canonical Wnt Signaling Pathways


